ONE-WAY CONFIDENTIAL DISCLOSURE AGREEMENT BETWEENWay Confidential Disclosure Agreement • November 7th, 2020 • Berlin
The receiving party desires to review or evaluate subjects of interest relating to PharmaSol’s GmbH (“PHARMASOL”) respective products, technologies, and business arrangements to make an evaluation of the financial, technical and commercial consequences of a potential alliance, partnership or other collaboration between the Parties (“the Purpose”). The parties contract on their own behalf and for their respective subsidiaries and affiliated companies.
TWO-WAY CONFIDENTIAL DISCLOSURE AGREEMENTWay Confidential Disclosure Agreement • September 16th, 2020 • District of Columbia
This Confidential Disclosure Agreement (“Agreement”) is in furtherance of the Federal Technology Transfer Act of 1986, as amended (15 U.S.C. §§ 3710a et seq.), and 38 U.S.C. §7303. This Agreement is effective as of the last signature date and is by and between the Department of Veterans Affairs located at (enter name and address of the VAMC) referred to as “VA” and (name and address of company), referred to as “INSTITUTION,” together collectively referred to as “PARTIES.”
